Eclampsia is one of the most common pregnancy complications causing high mortality and morbidity for both mother and foetus especially in developing countries. Many studies suggest that elevated homocysteine level is an important risk factor for eclampsia. The aim of this study was to explore the association between serum homocysteine with eclampsia and to establish serum homocysteine measurement as a reliable test for early detection of eclampsia. In a case control study serum homocysteine and lipid profile were measured in 52 controls (healthy uncomplicated pregnant women) and 50 eclamptic pregnant women. Serum homocysteine in eclampsia cases (10.44±4.08 µmol/L) found to be significantly increased (p< 0.001) compared to controls (7.97±3.46 µmol/L). Serum HDL-cholesterol concentration found to be significantly decreased (p<0.001) in the cases (35.98±6.35 mg/dl) compared to controls (42.69±6.09 mg/dl). A significant negative correlation (r-.801, p<0.01) was found between serum homocysteine and HDL-cholesterol concentration among cases. It can be concluded that elevated serum homocysteine and HDL-cholesterol deficiency were associated with eclampsia. But elevated homocysteine itself might be a factor associated with eclampsia irrespective of lipid profile status.
Introduction
Pre-eclampsia/eclampsia is a pregnancy specific disorder, which complicates 7-10% of all gestations 1 . Approximately 10-15% of maternal deaths in developing countries are associated with pre-eclampsia and eclampsia 2 . Pre-eclampsia is a triad of oedema, hypertension and proteinuria occurring primarily after the 20th gestational week and most frequently near term 3 . Pre-eclampsia when complicated with convulsion and or coma is called eclampsia 4 . Intrauterine growth retardation (IUGR), pre-term delivery, low birth weight, foetal death and neonatal death due to complications of pre-term delivery are common perinatal outcomes associated with pre-eclampsia 5 . Pre-eclampsia and eclampsia is still regarded as "a disease of theories" and its etiology is still obscured.
Endothelial cell dysfunction appears to be a central feature in the pathophysiology of pre-eclampsia 6 . Homocysteine is a sulfur containing amino acid primarily derived from the metabolic demethylation of dietary methionine required for the growth of cells and tissue in the human body 7 . Most recently homocysteine has been claimed as a factor for vascular endothelial cell injury in pre-eclampsia and its consequences 8 . Homocysteine by auto oxidation generates super oxide and hydrogen peroxide, both of which damage the arterial endothelial lining or cause endothelial dysfunction 9 . Levels of maternal serum homocysteine normally decreased in normal pregnancy, either due to hemodilution from increased plasma volume or the relative deficiency during pregnancy 10 . Dyslipidemia also plays a role in the aetiopathogenesis of eclampsia 5 . Human gestation is associated with an atherogenic lipid profile that is further enhanced in pre-eclampsia. Such profile may also be a potential contributor to endothelial cell dysfunction, which is a central feature in the pathophysiology of eclampsia 11 . Some studies have demonstrated the relationship between particular serum lipid and levels of homocysteine in eclampsia patients 12 . Eclampsia is associated with 10 percent of maternal deaths and each year approximately 50,000 women worldwide lose their lives out of this complication 2 . Bangladesh is a densely populated country, like many other developing countries, is facing various health related problems including high maternal mortality, which is 3.15 per 1000 women 13 . In Bangladesh, the incidence of eclampsia is alarmingly high, about 16% of maternal deaths are associated with it 14 . The homocysteine-mediated vascular changes are similar to those associated with pre-eclampsia; therefore a hypothesis has been proposed that elevated homocysteine may be associated with this condition 15 . Elevated blood levels of homocysteine are now recognized as an important risk marker for pre-eclampsia and eclampsia 1 . Many studies have demonstrated the relationship between elevated homocysteine and pre-eclampsia or eclampsia 10, [15] [16] [17] [18] [19] [20] . In Bangladesh, study on homocysteine is very scanty. No reported study so far has been observed on homocysteine in eclampsia. Increased level of homocysteine might be an independent factor associated with eclampsia in Bangladeshi women as well. It could be possible to bring health benefits to people of this country by treating hyperhomocysteinemia, if it is proved to be associated with eclampsia. So this case control study was designed in Bangladeshi population to evaluate the serum homocysteine concentration in eclamptic patients that might be helpful for the prognosis and management of eclampsia in Bangladesh.
Materials and Methods
Hospital. Study subjects of both groups were apparently matched with respect to maternal age, gestational age and BMI. Ethical clearance and permission for the study was taken from the concerned Departments and authorities. Informed written consent was taken from patients/ attendants from all the study subjects. With all aseptic precaution morning blood samples of all the study subjects were collected. After centrifuging the blood, serum was separated and stored at -70°C. Serum homocysteine concentration was analyzed by fluorescence polarization immunoassay (FPIA) method by Abbot's AxSYM system 21 and lipid profile was analyzed by enzymatic colorimetric method 22 . The data were analyzed statistically by using SPSS (version 12.00 for Windows). Student's unpaired 't' test was performed to see the differences between two groups. The relationship between the variables was explained by the Pearson's correlation test. For all the statistical analyses 2-tailed p values <0.05 were considered as significant.
Results
The study revealed the mean serum homocysteine concentration in cases was 10.44±4.08 µmol/L and in controls was 7.97±3.46 µmol/L. Among the cases serum homocysteine found significantly increased in comparison to controls (p<0.001). Serum HDLcholesterol concentration found significantly decreased (p<0.001) in the cases (35.98±6.35 mg/dl) compared to controls (42.69±6.09 mg/dl). But no significant differences were found between the cases and controls in respect to serum cholesterol, triacylglycerol and LDLcholesterol. This study also revealed a significant negative correlation (r = -.801, p <0.01) between serum homocysteine and HDL-cholesterol among the cases. But no significant correlation was observed between homocysteine and other components of lipid profile.
Discussion
Eclampsia is one of the most leading causes of maternal and perinatal mortality in the developing countries. Approximately 10-15% of maternal deaths in developing countries are associated with pre-eclampsia and eclampsia 2 . In Bangladesh about 16% of maternal deaths are associated with it 14 . This figure is quite alarming. So it would be better to diagnose this disease before its clinical manifestations. The prevention of the onset of the disease would have a significant improvement in the maternal and child health. The present study was undertaken to study the changes of some biochemical parameters in eclamptic Bangladeshi women, which may contribute to the proper diagnosis and management of this disease.
Many studies have demonstrated the relationship between elevated homocysteine and pre-eclampsia; or eclampsia 20 . In this study mean serum homocysteine level was found to be significantly high (p <0.001) in eclampsia cases as compared to their control value. In consistent with presented findings Rajkovic et al 16 , Vandergajt et al 12 and Cotter et al 6 also found homocysteine concentration to be raised in eclampsia patients. Makedos et al. 19 , Wang et al. 8 , Aubard et al. 23 , Powers et al 18 demonstrated the relationship between hyperhomocysteinemia and preeclampsia without showing any attention to the severity of pre-eclampsia; and degree of hyperhomocysteinemia. Present study also revealed significantly low (p <0.001) serum HDL-C concentration in cases compared to controls, which is similar to the studies conducted by Ware-Jauregui et al 5 25 . Reported study also revealed a significant negative correlation between serum homocysteine and HDL-C in eclampsia cases. No significant correlation was found between homocysteine and other components of lipid profile (TC, TG, LDL-C), which is consistent with the findings of Vandergajt et al 12 and Powers et al 18 . This study observed significantly increased serum homocysteine level and decreased HDL-C without any significant changes in TC, TG and LDL-C in eclampsia cases compared to control. Moreover serum homocysteine demonstrated no significant correlation with lipid profile except the negative correlation with serum HDL-C in eclampsia cases. Thus, serum homocysteine appears to be an independent factor associated with eclampsia irrespective of lipid profile status.
Conclusion
It can be concluded from this study that increased homocysteine level and isolated HDL-C deficiency are associated with eclampsia. Decreased HDL-C and increased homocysteine level may have additive or synergistic effect on pathophysiology of eclampsia. Early detection is the corner stone for proper management of eclampsia, which will reduce the maternal mortality rate and infant mortality rate. For early detection a reliable, simple and inexpensive laboratory test is essential. Serum homocysteine measurement can be used for this purpose. So serial estimation of serum homocysteine could be advised from the 1st trimester of pregnancy for early detection of pre-eclampsia and eclampsia. Folate, vitamin B 12 and vitamin B 6 are involved in the metabolism of homocysteine 28 . Elevated homocysteine is a marker of low vitamin B status or decreased methylation capacity of cells 29, 30 . So vitamin B 6 , B 12 and folic acid supplementation could have a role in preventing the elevation of homocysteine in pregnant women 29 . Pregnant ladies having increased homocysteine may bring under special management with the target to normalize their serum homocysteine with vitamin B 6 , B 12 and folic acid supplementation to prevent eclampsia. But the use of serum homocysteine measurement as a screening test for eclampsia warrants further investigation.
